According to iBio's latest financial reports the company has โน0.59 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-06-30 | โน1.18 B | 235.58% |
2023-06-30 | โน0.35 B | -86.65% |
2022-06-30 | โน2.64 B | -63.29% |
2021-06-30 | โน7.20 B | 72.68% |
2020-06-30 | โน4.17 B | 1268.63% |
2019-06-30 | โน0.30 B | -72.05% |
2018-06-30 | โน1.09 B | 108.14% |
2017-06-30 | โน0.52 B | -66.23% |
2016-06-30 | โน1.55 B | 156.45% |
2015-06-30 | โน0.60 B | 180.69% |
2014-06-30 | โน0.21 B | -17.98% |
2013-06-30 | โน0.26 B | -15.83% |
2012-06-30 | โน0.31 B | 145.31% |
2011-06-30 | โน0.12 B | 201.43% |
2010-06-30 | โน42.22 M | -15.01% |
2009-06-30 | โน49.67 M | 5999.8% |
2008-06-30 | โน0.81 M | 6.67% |
2007-06-30 | โน0.76 M |